← Back to Search

Behavioral Intervention

mHealth Intervention + EMA for Child Abuse

N/A

Waitlist Available

Led By David Bard, PhD

Research Sponsored by University of Oklahoma

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Any new or currently enrolled parent in Oklahoma or Tulsa County in MIECHV-funded home visiting programs.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to follow-up (1-3 months post-intervention)

Awards & highlights

Study Summary

This trial aims to help parents improve their interactions with their children and increase their resilience. Parents participating in home visiting programs will receive daily messages on a smartphone app with tips on monitoring and promoting child development.

Who is the study for?

This trial is for new or current parents in Oklahoma or Tulsa County enrolled in MIECHV-funded home visiting programs. It aims to help them improve their parenting skills and child development through a mobile app.Check my eligibility

What is being tested?

The study tests an mHealth intervention that delivers daily tailored messages with parenting tips via a smartphone app, alongside assessments of parent-child interactions over a 4-week period.See study design

What are the potential side effects?

There are no direct physical side effects expected from the mHealth intervention as it involves receiving information and completing assessments on a smartphone app.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to follow-up (1-3 months post-intervention)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to follow-up (1-3 months post-intervention)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to follow-up (1-3 months post-intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Parent Satisfaction with App: Ease of Use and Satisfaction Survey

Parenting Behavior: Alabama Parenting Questionnaire

Parenting Behavior: EMA Data on Parent Response to Child Positive and Negative Behavior

+3 more

Secondary outcome measures

Child Adversity Exposure: Parent-Child Conflict Scale

Child Behavior: EMA Data Positive and Negative Behaviors

Child Development

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: mHealth Intervention + EMAExperimental Treatment1 Intervention

When families are in the mHealth intervention condition, the mHealth app will deliver parenting tips and strategies daily for 14 days. Furthermore, we plan to administer brief surveys via the mHealth app twice once a day at a pre-determined time. These surveys will ask parents to provide information about where they are and with whom, their emotional state, any recent parent-child interactions, and any current stressors or challenges. Parents will receive these daily surveys and the parenting tips for every day for two weeks. Then they will switch to EMA Only + Services As Usual.

Group II: EMA Only+ Services As UsualActive Control1 Intervention

In the EMA only condition, families will continue to receive services utilizing the home visiting model for the program they are enrolled in, including modules on healthy parent-child interaction and promoting parenting skills in high-risk families, but they will not receive parenting tips via the mHealth app during this period (2 weeks). Then, they will switch to mHealth Intervention + EMA.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

mHealth Intervention

2020

N/A

~190

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor

455 Previous Clinical Trials

97,579 Total Patients Enrolled

David Bard, PhDPrincipal InvestigatorUniversity of Oklahoma

1 Previous Clinical Trials

242 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals of a certain age excluded from participating in this trial?

"Per the study's stated inclusion criteria, individuals between 0 and 99 years of age are eligible for participation."

Answered by AI

What is the current participant quota for this research project?

"Affirmative. According to clinicaltrials.gov, this trial was initially posted on November 7th 2022 and is actively recruiting participants at present time. 200 individuals are being sought for the project which will be conducted at a single site."

Answered by AI

What is the main focus of this research undertaking?

"This trial, which will be evaluated over a period of 1-3 months post-intervention, aims to measure changes in parenting behavior through the Alabama Parenting Questionnaire. Further secondary outcomes include child development (Development Profiles-4), Child Adversity Exposure (Parent-Child Conflict Scale; 0 - 7 scale with higher numbers representing more frequent parenting behaviors associated with maltreatment) and Ages and Stages 3 survey for children's developmental progress."

Answered by AI

Are there any opportunities currently available for individuals to participate in this clinical trial?

"As indicated on clinicaltrials.gov this trial is urgently seeking participants, and was first made available to the public on November 7th 2022 with its latest update occurring two days later."

Answered by AI

Am I able to register as a participant in this investigation?

"This research is welcoming 200 individuals of all ages who have developmental needs and are either currently enrolled or eligible to enrol in MIECHV-funded home visiting programs located within Oklahoma or Tulsa County."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Promoting Resilience and Lowering Risk in Early Childhood

2022. "Promoting Resilience and Lowering Risk in Early Childhood". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05479734.